Vanguard Personalized Indexing Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
Vanguard Personalized Indexing Management's HCAT Position: Q2 2026 in Review
Vanguard Personalized Indexing Management reduced its Health Catalyst (HCAT) stake by 61% in Q2 2026, selling an estimated $40.3K and leaving 18,119 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2168.
Vanguard Personalized Indexing Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $58.5K in Q1 2026. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Vanguard Personalized Indexing Management held 18,119 shares of Health Catalyst worth $36.1K as of Q2 2026.
- Vanguard Personalized Indexing Management sold 27,935 Health Catalyst shares in Q2 2026, an estimated $40.3K.
- Health Catalyst made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2168 holding.
- Vanguard Personalized Indexing Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
- Vanguard Personalized Indexing Management's Health Catalyst position peaked at $58.5K in Q1 2026.
- 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.